SEP 29, 2016 10:00 AM PDT

Advancing Personalized Medicine through whole-genome profiling

SPONSORED BY: Affymetrix, Affymetrix
10 29 3768

  • Assistant Professor, Pathology & Laboratory Medicine, Associate Director, Pathology Residency Program, Emory University
      Dr. Stewart G. Neill received his MD degree from Emory University School of Medicine. He is currently an Assistant Professor of Pathology & Laboratory Medicine and Associate Director, Pathology Residency Program at Emory University.

    DATE:  September 29, 2016
    TIME:  10:00am PT, 1:00pm ET

    One of the challenges with personalized medicine lies in the identification of robust, clinically relevant biomarkers. Traditional approaches to biomarker discovery either focus on only a subset of the potential targets, or have insufficient resolution to discriminate small or rare changes that may carry biological significance.

    Recent technological advancement has made high-resolution whole-genome and whole-transcriptome profiling a reality. Translational researchers can now simultaneously search broadly and deeply to efficiently identify potential biomarkers from samples in a matter of days, without requiring resource-intensive bioinformatics support.

    During the webinar, Dr. Stewart Neill will:
    • Discuss the importance of copy number variation and copy-neutral loss of heterozygosity in the modern classification and subclassification of CNS neoplasia
    • Demonstrate how advancements in technologies with greater sensitivity can detect important cytogenomic events that are driving the discovery of novel biomarkers
    • Illustrate the use of microarray-based technologies in a clinical research setting through a case study approach
    • Answer your questions live during the broadcast!

    Show Resources
    Loading Comments...